hig.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market - Consequences for costs and availability
University of Gävle, Department of Business Administration and Economics, Ämnesavdelningen för nationalekonomi. The Swedish Retail Institute, Stockholm, Sweden.
2008 (English)In: Health Policy, ISSN 0168-8510, E-ISSN 1872-6054, Vol. 87, no 2, 258-263 p.Article in journal (Refereed) Published
Abstract [en]

Objectives: The objective of this study is to analyze the impact of the new regulation concerning entry of pharmacies into the Norwegian pharmaceuticals market in 2001 on cost and availability of pharmaceutical products. Methods: In order to study costs, a translog cost function is estimated using data from the annual reports of a sample of Norwegian pharmacies before and after the deregulation of the market. Linear regression models for the number of pharmacies in each region in Norway are also estimated. Results: The results show that the costs of the individual pharmacies have not decreased as a consequence of the deregulation of the Norwegian pharmaceuticals market. The deregulation of the market did, however, increase the availability to pharmacy services substantially. Conclusions: Increased availability of pharmacy services can be achieved by deregulating pharmaceutical markets as in Norway, but at the expense of increased costs for the pharmacies. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

Place, publisher, year, edition, pages
2008. Vol. 87, no 2, 258-263 p.
Keyword [en]
deregulation, entry, pharmaceuticals, translog cost function
National Category
Economics
Identifiers
URN: urn:nbn:se:hig:diva-10296DOI: 10.1016/j.healthpol.2007.10.016ISI: 000257829100012Scopus ID: 2-s2.0-45549093048OAI: oai:DiVA.org:hig-10296DiVA: diva2:442955
Available from: 2011-09-22 Created: 2011-09-21 Last updated: 2016-10-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Rudholm, Niklas
By organisation
Ämnesavdelningen för nationalekonomi
In the same journal
Health Policy
Economics

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 32 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf